ConductScience.org, home

Trial · NCT01603394

Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in the Daily Pain Diary (Numerical Rating Scale, NRS) Mean Pain Score at the End of the Study (Week 6).Baseline, Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYNeuropathic Pain Symptom Inventory (NPSI) at All Visits.All visitsOnly 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYProportion of Phenotypes Within the 30% and 50% Responder Groups at Baseline and Week 6.Baseline, Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYPatient Global Impression of Change (PGIC) at Week 6/Early Termination.Week 6/Early TerminationOnly 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYProportions of Participants With >/=30% and >/=50% Pain Reduction Based on Daily Pain Diary at Baseline and Week 6.Baseline, Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYProportion of Participants Within Each Phenotype Group as Determined by Sensory Symptom Clustering Using the PainPREDICT, PainDETECT and Neuropathic Pain Symptom Inventory at Baseline and Week 6.Baseline, Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYPatient Health Questionnaire-8 (PHQ-8) at Baseline and Week 6; Generalized Anxiety Disorder-7 (GAD-7) at Screening, Visit 2 (Week 0) and Week 6/Early Termination.Screening, Visit 2 (Week 0) and Week 6/Early TerminationOnly 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYBrief Pain Inventory (BPI sf) at Visit 2 (Week 0) and Week 6.Visit 2 (Week 0), Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYPatient Catastrophizing Scale (PCS) at Visit 2 (Week 0) and Week 6.Visit 2 (Week 0), Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYPain NRS Score; 1 Week Recall Period.1 WeekOnly 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYShort Form 12v2 Health Survey (SF 12v2) at Visit 2 (Week 0), and Week 6/Early Termination.Visit 2 (Week 0), and Week 6/Early TerminationOnly 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.
SECONDARYChange From Baseline to End of the Study (Week 6) in the Daily Sleep Interference Diary (NRS) Mean Pain Score.Baseline, Week 6Only 9 of the 200 participants were enrolled into the trial, so we are unable to get adequate results from this study.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01603394/outcomes